Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, June 30, 2023
[ Fri, Jun 30th 2023
] - WOPRAI
[ Fri, Jun 30th 2023
] - WOPRAI
Thu, June 29, 2023
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
[ Thu, Jun 29th 2023
] - WOPRAI
Raghuram Selvaraju Reiterated (AVXL) at Strong Buy and Held Target at $54 on, Jun 29th, 2023
Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Anavex Life Sciences Corp." (AVXL) at Strong Buy and Held Target at $54 on, Jun 29th, 2023.
Raghuram, nor any peers, have made any analyst calls on AVXL in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30